Evaluation Of The Efficacy and Safety Of Tri-ActiveTM In Treatment Of Cellulite

Inclusion Criteria: 1. Written Informed Consent; 2. Subjects agreeing to take part of all procedures of the study (including mechanical massage, photographs), after being fully informed on the objectives and nature of the investigations; 3. Female subjects between 18-45 years; 4. Subjects presenting with cellulite grades I-III on buttocks and thighs; 5. Medical history and physical examination which, based on the investigator's opinion, do not prevent the patient from taking part in the study and use the device under investigation; 6. Female subjects of childbearing age should present a negative urine pregnancy test and should be using an effective contraceptive method (3 months before the enrollement untill the end of the study); 7. Body Mass Index (BMI = weight/height2) beetwen 20,0-25,0; 8. Availability of the subject throughout the duration of the study (60 days); 9. Availability of the subject in maintaining a stable weight during the study (variation less than 2 kg) 10. Subjects with sufficient schooling and awareness to enable them to cooperate to the degree required by this protocol. Exclusion Criteria: 1. Pregnant women or women intending to become pregnant during the study (next 3 months); 2. BMI superior 25,0; 3. Subjects with diabetes mellitus, cardiac insufficiency, asthma, or bronchitis; 4. Subjects participating in other clinical trials; 5. Subjects with neoplastic disorders, uncontrolled thyroid disorders or uncontrolled hypertension; 6. Subjects with coagulation disorders, using anticoagulants or tendency of bruises; 7. Subjects with vascular disorders (phlebitis or varicose veins) in the area to be treated; 8. Any prior aesthetic surgery affecting the area to be treated (liposuction, Subcision®), 3 months before the study, that may interfere with results; 9. Any other prior anti-cellulite treatment or body measures treatment, 30 days prior to the study; 10. Subjects with inflammation or active infection in the area to be treated. 11. Subjects with a history of adverse effects, which in the investigator's opinion should prevent the patient from participating in the study; 12. Patients with cutaneous or vascular alterations, that difficult visualization and documentation of cellulite; 13. Subjects with a history of medical treatment non-adherence or showing unwillingness to adhere to the study protocol; 14. Subjects who can not come to the visits (one missing visit/ month is allowed); 15. Subjects intending to initiate any intensive sport; 16. Subjects using analgesics, non-hormonal antiinflammatories, antihistaminics, corticosteroids, or diuretics; 17. Subjects tanned, or intending to expose the area of study to sun, artificial UV, or self-tanning during the study; 18. Any condition that, in the opinion of the investigator, can compromise the evaluation of the study.